Preparation method and application of animal bifidobacterium F1-7 and euphausia superba oil composition for improving atherosclerosis inflammation
A technology for animal bifidobacteria, atherosclerosis, applied in the direction of bifidobacteria, drug combinations, bacteria used in food preparation, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] Embodiment 1, Bifidobacterium animalis F1-7 and krill oil mixture have atherosclerosis improving effect
[0026] HE staining of cardiovascular tissue ( figure 2 ), Atherosclerosis Group Aope - / - Cardiovascular endothelial cells in mice were extensively damaged and shed, with lipid deposition, vacuolated cytoplasm of smooth muscle cells, loose and slightly stained cytoplasm, disordered arrangement of smooth muscle cells, and large plaque-like substances were clearly visible on the inner wall of blood vessels. In the krill oil group, a small amount of plaque was attached to the inner wall, and the cardiovascular intima of the mice was slightly damaged. The smooth muscle cells were arranged neatly, with hyperplasia, increased nucleus density, and some smooth muscle cells had vacuolar changes. However, in the probiotic group and the combination group of Bifidobacterium animalis F1-7 and krill oil, there was basically no plaque deposition. The intima of the cardiac arterie...
Embodiment 2
[0027] Embodiment 2, anti-inflammatory effect of bifidobacterium animal F1-7 and krill oil mixture
[0028] The level of inflammatory changes in mice with atherosclerosis was measured, and it was found that Bifidobacterium animalis F1-7, krill oil and the mixture of the two can effectively improve the serum inflammatory level of mice. Compared with AS group, Bifidobacterium animalis F1-7, krill oil and the combination of Bifidobacterium animalis F1-7 and krill oil could significantly reduce IL-1β in serum ( image 3 ) and TNF-α ( Figure 4 ), and there was no statistical difference among the groups.
[0029] TLR4 immunohistochemical staining ( Figure 5 ) showed that compared with AS in the atherosclerosis model group, Bifidobacterium animalis F1-7, krill oil and the mixture of the two groups significantly decreased the TLR4 positive area, in which the combination of Bifidobacterium animalis F1-7 and krill oil The effect is better than the other two groups. The immunohisto...
Embodiment 3
[0030] Example 3, Anti-inflammatory Mechanism of Animal Bifidobacterium F1-7 and Krill Oil Mixture
[0031] Determination of the expression of inflammatory response-related genes in the intestine ( Figure 6 ). Compared with AS group, Bifidobacterium animalis F1-7, krill oil and their mixture can significantly reduce the expression of TNF-α. Among them, the effect of Bifidobacterium animalis F1-7 and krill oil group was significantly better than that of the other two groups. After the intervention of probiotics, krill oil and the mixture, the expression of IL-1β was significantly reduced, and there was no difference among the groups. The intervention group can also effectively reduce the expression of key genes in the TLR4 / MYD88 / NF-κB pathway, thereby inhibiting the levels of downstream inflammatory factors TNF-α and IL-1β. Bifidobacterium animalis F1-7 and krill oil had no difference in the effect of regulating TLR4 and MYD88, and the combination of Bifidobacterium animali...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com